Litigation Details for CELGENE CORPORATION v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2017)
✉ Email this page to a colleague
CELGENE CORPORATION v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2017)
Docket | ⤷ Try a Trial | Date Filed | 2017-04-12 |
Court | District Court, D. New Jersey | Date Terminated | 2021-03-24 |
Cause | 35:145 Patent Infringement | Assigned To | Susan Davis Wigenton |
Jury Demand | None | Referred To | Leda Dunn Wettre |
Patents | 6,465,477; 7,915,307; 8,298,576; 8,298,580; 8,663,683; 8,877,248; 8,889,191; 8,992,989 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in CELGENE CORPORATION v. ZYDUS PHARMACEUTICALS (USA) INC.
Details for CELGENE CORPORATION v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-01-08 | 69 | The Patent in Suit 14. I Jnited States Patent No. 6,465,477 ("the '…the “’989 Patent,” and together with the ’576 Patent, the ’580 Patent, the ’683 Patent, the ’248…enforceability or patentability of any of the Licensed Patents or to seek reexamination of those patents in any …enforceability or patentability of any of the Licensed Patents, or in seeking reexamination of such patents, in any…infringement of U.S. Patent Nos. 6,211,229 (the “’229 patent”) and 7,915,307 (the “’307 patent”) in connection | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |